Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Enterprise Value: 2013-2025

Historic Enterprise Value for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $33.2 million.

  • Fortress Biotech's Enterprise Value rose 155.53% to $33.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$189.8 million, marking a year-over-year increase of 36.88%. This contributed to the annual value of -$25.7 million for FY2024, which is 65.66% up from last year.
  • As of Q3 2025, Fortress Biotech's Enterprise Value stood at $33.2 million, which was up 228.04% from -$25.9 million recorded in Q2 2025.
  • Fortress Biotech's Enterprise Value's 5-year high stood at $212.5 million during Q2 2021, with a 5-year trough of -$98.8 million in Q4 2022.
  • For the 3-year period, Fortress Biotech's Enterprise Value averaged around -$45.6 million, with its median value being -$59.8 million (2024).
  • Per our database at Business Quant, Fortress Biotech's Enterprise Value skyrocketed by 263.98% in 2021 and then tumbled by 263.25% in 2022.
  • Over the past 5 years, Fortress Biotech's Enterprise Value (Quarterly) stood at $60.5 million in 2021, then plummeted by 263.25% to -$98.8 million in 2022, then increased by 24.14% to -$75.0 million in 2023, then soared by 65.66% to -$25.7 million in 2024, then soared by 155.53% to $33.2 million in 2025.
  • Its Enterprise Value was $33.2 million in Q3 2025, compared to -$25.9 million in Q2 2025 and -$35.0 million in Q1 2025.